Implementation of Support in the Care of Adults Living With Type 1 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMcGill University

About this trial

The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.

Eligibility criteria

Qualifiers

Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)

Have access to Internet

Use of an active email address

Comprehension of English or French

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Support platform

Treatment groups

322 Participants
are divided into 2 treatment groups

Sponsors and collaborators

McGill University

Lead sponsor

Institut de Recherches Cliniques de Montreal

Collaborator

Centre de Recheche du Centre Hospitalier Université Laval

Collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborator

Centre de médecine métabolique de Lanaudière

Collaborator